SUBSCRIBE
SUBSCRIBE

Iovance Biotherapeutics, Inc.

NEWS
Business
10 Women Biotech CEOs Lead the Charge
The general consensus is that only about seven to nine percent of chief executive roles in biotech are filled by women. As low as that sounds, it’s better than in the Fortune 500, where only about 4.2 percent are led by female chief executives.
May 28, 2018
 · 
4 min read
 · 
Mark Terry
Gemini Therapeutics Banks $42.5M to Bring Precisio
Biotech Bay
2 Bay Area Biotechs That Jumped While Its Peers Cratered
Since Friday, the stock market has been volatile, to say the least.
February 7, 2018
 · 
2 min read
 · 
Mark Terry
3 Biotechs That Got Huge Boosts From Spark's FDA P
Biotech Bay
3 Under-the-Radar Bay Area Biotechs That Could Double in 2018
Biotech stocks are generally viewed as highly volatile. Of course, along with volatility comes the possibility for huge upside rewards.
October 18, 2017
 · 
2 min read
 · 
Mark Terry
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Lion Biotech Raises Approximately $100 Million and Names a New CEO
June 6, 2016
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
November 1, 2024
 · 
8 min read
Business
Iovance Biotherapeutics to Present at Upcoming Conferences
September 3, 2024
 · 
6 min read
Business
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
August 8, 2024
 · 
23 min read
Business
Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
July 29, 2024
 · 
6 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - July 19, 2024
July 22, 2024
 · 
7 min read
Biotech Bay
Iovance Biotherapeutics to Present at Upcoming Conferences and Events - May 24, 2024
May 24, 2024
 · 
6 min read
Biotech Bay
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
May 23, 2024
 · 
10 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 17, 2024
May 17, 2024
 · 
7 min read
Business
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
May 9, 2024
 · 
18 min read
Business
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
May 1, 2024
 · 
6 min read
Load More